CN1086997A - 一种使用血管舒张药的治疗方法 - Google Patents

一种使用血管舒张药的治疗方法 Download PDF

Info

Publication number
CN1086997A
CN1086997A CN93116247A CN93116247A CN1086997A CN 1086997 A CN1086997 A CN 1086997A CN 93116247 A CN93116247 A CN 93116247A CN 93116247 A CN93116247 A CN 93116247A CN 1086997 A CN1086997 A CN 1086997A
Authority
CN
China
Prior art keywords
nitrites
accordance
patient
angina pectoris
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN93116247A
Other languages
English (en)
Chinese (zh)
Inventor
H·L·芳格
J·A·保尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Branded Pharmaceutical Products R&D Inc
Original Assignee
Baker Cummins Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Cummins Pharmaceuticals Inc filed Critical Baker Cummins Pharmaceuticals Inc
Publication of CN1086997A publication Critical patent/CN1086997A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN93116247A 1992-07-02 1993-07-02 一种使用血管舒张药的治疗方法 Pending CN1086997A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/908,224 US5278192A (en) 1992-07-02 1992-07-02 Method of vasodilator therapy for treating a patient with a condition
US07/908,224 1992-07-02

Publications (1)

Publication Number Publication Date
CN1086997A true CN1086997A (zh) 1994-05-25

Family

ID=25425396

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93116247A Pending CN1086997A (zh) 1992-07-02 1993-07-02 一种使用血管舒张药的治疗方法

Country Status (19)

Country Link
US (2) US5278192A (enExample)
EP (1) EP0604642A1 (enExample)
JP (1) JP2729333B2 (enExample)
KR (1) KR0170789B1 (enExample)
CN (1) CN1086997A (enExample)
AU (1) AU667948B2 (enExample)
CA (1) CA2116785C (enExample)
CZ (1) CZ39894A3 (enExample)
HU (1) HUT70501A (enExample)
IL (1) IL106217A (enExample)
MX (1) MX9303982A (enExample)
NO (1) NO305886B1 (enExample)
NZ (1) NZ254490A (enExample)
OA (1) OA09890A (enExample)
PL (1) PL302613A1 (enExample)
SK (1) SK23594A3 (enExample)
TW (1) TW261530B (enExample)
WO (1) WO1994001103A1 (enExample)
ZA (1) ZA934771B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113164427A (zh) * 2018-11-27 2021-07-23 阿特格诺有限公司 用于制备亚硝基化丙二醇的方法、包含其的组合物及其医学用途

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
US5973011A (en) * 1994-03-30 1999-10-26 Isis Pharma Gmbh Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
US5665077A (en) * 1995-04-24 1997-09-09 Nitrosci Pharmaceuticals Llc Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
US5658936A (en) * 1995-09-18 1997-08-19 Brigham & Women's Hospital, Inc. Enhancement of erectile function with renin-angiotensin system inhibitors
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US5897880A (en) 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US6251436B1 (en) 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6387407B1 (en) 1995-09-29 2002-05-14 L.A.M. Pharmaceutical Corporation Topical drug preparations
WO1997027745A1 (en) * 1996-01-31 1997-08-07 Technology Licensing Co. L.L.C. Method of diagnosis and treatment and related compositions and apparatus
US6258032B1 (en) * 1997-01-29 2001-07-10 William M. Hammesfahr Method of diagnosis and treatment and related compositions and apparatus
GB9608408D0 (en) 1996-04-23 1996-06-26 Adams Michael A Treatment of erectile dysfunction
US5797887A (en) * 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
US5958884A (en) * 1997-04-11 1999-09-28 The Brigham And Women's Hospital, Inc. Compositions and methods for treating erectile dysfunction
US6191156B1 (en) 1997-04-11 2001-02-20 The Brigham And Women's Hospital, Inc. Compositions and methods for treating bladder dysfunction
ZA989356B (en) * 1997-10-16 1998-11-16 Isis Pharma Gmbh Pharmaceutical preparations
US6056966A (en) * 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
US6314956B1 (en) 1999-09-08 2001-11-13 Duke University Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
US7045152B2 (en) 1999-09-08 2006-05-16 Duke University Treating pulmonary disorders with gaseous agent causing repletion of GSNO
CA2410632A1 (en) 2000-06-22 2001-12-27 David S. Garvey Nitrosated and nitrosylated taxanes, compositions and methods of use
CN1267212C (zh) * 2000-08-11 2006-08-02 大卫·R·怀特洛克 氨氧化细菌在药物中的应用、由其制成的制剂及用其处理过的用品
US20020172712A1 (en) * 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
US7235523B2 (en) * 2001-04-13 2007-06-26 Children's Hospital Medical Center Methods for the treatment of hepatic disorders
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030138494A1 (en) * 2001-05-15 2003-07-24 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6676855B2 (en) * 2001-08-02 2004-01-13 Duke University Use of a blood-flow decrease preventing agent in conjunction with insufflating gas
US20040225275A1 (en) * 2001-08-02 2004-11-11 Reynolds James Dixon Fetal physiology during maternal surgery or diagnosis
JP2005515218A (ja) * 2002-01-11 2005-05-26 ホイットロック，デービッド，アール． アンモニア酸化細菌を含む組成物およびその使用方法
WO2003075832A2 (en) 2002-03-06 2003-09-18 Duke University Methods and composition based on discovery of metabolism of nitroclycerin
US7776925B2 (en) * 2002-03-06 2010-08-17 Duke University Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria
US20060263419A1 (en) * 2002-03-12 2006-11-23 Hans-Michael Wolff Transdermal therapeutic system for Parkinson's Disease
US8822473B2 (en) * 2002-05-21 2014-09-02 Gilead Sciences, Inc. Method of treating diabetes
CA2486712C (en) 2002-05-21 2012-01-03 Cv Therapeutics, Inc. Method of treating diabetes
US6936639B2 (en) * 2002-08-21 2005-08-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitroxyl progenitors in the treatment of heart failure
WO2005063221A1 (en) * 2003-12-19 2005-07-14 Duke University Measuring vasodilating activity of blood samples to track disease course
EP1865770A4 (en) * 2005-04-07 2010-12-29 Nitromed Inc ASSESSMENT OF GENETIC RISK IN CARDIAC ERRORS: IMPACT OF THE GENETIC VARIATION OF NOS3
WO2006134591A2 (en) * 2005-06-13 2006-12-21 Yeda Research And Development Co. Ltd. Use of allylmercaptocaptopril for treating or preventing obesity and obesity related diseases
WO2007041681A2 (en) * 2005-10-04 2007-04-12 Nitromed, Inc. Methods for treating respiratory disorders
CN101443292B (zh) * 2006-03-14 2012-07-18 拉斯·E·古斯塔夫森 制备治疗化合物和组合物的新方法、用该方法制备的化合物和组合物，及其用途
US7625852B2 (en) * 2006-06-07 2009-12-01 Henry Hadry Nail polish remover
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US9649334B2 (en) 2007-11-15 2017-05-16 The Uab Research Foundation Use of nitrite salts in chronic ischemia
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
US20120237617A1 (en) 2009-06-18 2012-09-20 Theravasc Inc. Use of nitrite salts in treating tissue damage
WO2011047161A1 (en) 2009-10-14 2011-04-21 TheraVasc, LLC Pharmaceutical formulations of nitrite and uses thereof
US20110160200A1 (en) * 2009-11-23 2011-06-30 Cardioxyl Pharmaceuticals, Inc. Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension
CA2782110A1 (en) * 2009-12-07 2011-06-16 Johns Hopkins University N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
JP5832447B2 (ja) 2009-12-07 2015-12-16 ザ ジョンズ ホプキンス ユニバーシティ ビスアシル化ヒドロキシルアミン誘導体
US10166381B2 (en) 2011-05-23 2019-01-01 Excelsior Medical Corporation Antiseptic cap
EP2731658B1 (en) 2011-07-12 2020-04-01 Pursuit Vascular, Inc. Device for delivery of antimicrobial agent into trans-dermal catheter
CN104869985A (zh) * 2012-08-23 2015-08-26 心脏林克斯股份公司 硝酸氨基烷基酯的延长释放组合物
BR112015019802A2 (pt) 2013-02-20 2017-07-18 Theravasc Inc formulações farmacêuticas de nitrito e usos das mesmas
KR102607213B1 (ko) 2014-04-15 2023-11-30 에이오바이오미 엘엘씨 암모니아-산화 니트로소모나스 유트로파 균주 d23
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
WO2015168677A1 (en) 2014-05-02 2015-11-05 Excelsior Medical Corporation Strip package for antiseptic cap
JP6822978B2 (ja) 2015-05-08 2021-01-27 アイシーユー・メディカル・インコーポレーテッド 治療薬のエミッタを受け入れるように構成された医療用コネクタ
AU2017341782B2 (en) 2016-10-14 2023-03-16 Icu Medical, Inc. Sanitizing caps for medical connectors
WO2018204206A2 (en) 2017-05-01 2018-11-08 Icu Medical, Inc. Medical fluid connectors and methods for providing additives in medical fluid lines
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
JP2022513096A (ja) 2018-11-21 2022-02-07 アイシーユー・メディカル・インコーポレーテッド リング及びインサートを有するキャップを備える抗菌装置
GB202007929D0 (en) * 2020-05-27 2020-07-08 Attgeno Ab New medical uses
US20240082198A1 (en) * 2020-10-01 2024-03-14 Emergent Product Development Gaithersburg Inc. Stabilized alkyl nitrite compositions
JP2024500319A (ja) 2020-12-07 2024-01-09 アイシーユー・メディカル・インコーポレーテッド 腹膜透析キャップ、システム、及び方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3106511A (en) * 1961-12-14 1963-10-08 Revlon Amyl nitrite inhalant composition
CA1163195A (en) * 1980-06-26 1984-03-06 Alec D. Keith Polymeric diffusion matrix containing a vasodilator
US4450175A (en) * 1982-09-23 1984-05-22 Warshaw Thelma G Method and compositions for treating acne
DE3305690A1 (de) * 1983-02-18 1984-08-30 Heinrich Mack Nachf., 7918 Illertissen Glycerinmononitrate zur behandlung der angina pectoris
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US4615699A (en) * 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
US4681584A (en) * 1985-05-03 1987-07-21 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
JPH06696B2 (ja) * 1987-01-27 1994-01-05 積水化学工業株式会社 テ−プ製剤
JPH06697B2 (ja) * 1987-01-27 1994-01-05 積水化学工業株式会社 テ−プ製剤
US4956181A (en) * 1987-05-08 1990-09-11 Eastman Kodak Nitrate therapy for angina pectoris
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113164427A (zh) * 2018-11-27 2021-07-23 阿特格诺有限公司 用于制备亚硝基化丙二醇的方法、包含其的组合物及其医学用途

Also Published As

Publication number Publication date
US5489610A (en) 1996-02-06
NO940691D0 (no) 1994-02-28
CZ39894A3 (en) 1994-11-16
NO940691L (no) 1994-03-18
WO1994001103A1 (en) 1994-01-20
NO305886B1 (no) 1999-08-16
OA09890A (en) 1994-09-15
ZA934771B (en) 1994-01-20
NZ254490A (en) 1997-08-22
AU667948B2 (en) 1996-04-18
HU9400627D0 (en) 1994-06-28
US5278192A (en) 1994-01-11
JP2729333B2 (ja) 1998-03-18
KR0170789B1 (ko) 1999-02-01
IL106217A (en) 1998-04-05
JPH06510800A (ja) 1994-12-01
MX9303982A (es) 1994-02-28
HUT70501A (en) 1995-10-30
EP0604642A1 (en) 1994-07-06
SK23594A3 (en) 1994-08-10
CA2116785C (en) 1998-04-07
TW261530B (enExample) 1995-11-01
IL106217A0 (en) 1993-11-15
AU4658793A (en) 1994-01-31
PL302613A1 (en) 1994-09-05
CA2116785A1 (en) 1994-01-20

Similar Documents

Publication Publication Date Title
CN1086997A (zh) 一种使用血管舒张药的治疗方法
Lemmer et al. Chronopharmacology and chronotherapeutics: definitions and concepts
Lemmer Circadian rhythms and drug delivery
CN1127473A (zh) 以促孕剂和氧化氮合酶底物和/或供体的结合物治疗子痫前期和早产
JP3895767B2 (ja) β−受容体ブロッカーおよび局所麻酔剤の新規な組合せ
CN1181699A (zh) 用于治疗心血管疾病的氨基四氢化萘衍生物
CN119632973A (zh) 漆黄素制备治疗心脏有关疾病的药物中的应用
CN118512434A (zh) N-乳酰苯丙氨酸在制备防治缺血性心脏病药物中的用途
INADA et al. Antihypertensive action of a new angiotensin converting enzyme inhibitor,(R)-3-[(S)-1-carboxy-5-(4-piperidyl) pentyl] amino-4-oxo-2, 3, 4, 5-tetrahydro-1, 5-benzothiazepine-5-acetic acid (CV-5975), in various hypertensive models
BRUNGARDT et al. Adrenergic mechanisms in canine hindlimb circulation
CN102670597B (zh) 5-(4-羟基-3-甲氧基苯亚甲基)罗丹宁在制备治疗帕金森氏病药物中的用途
CN104586835B (zh) 穿心莲内酯的医药用途
US12419887B2 (en) Transitioning patients treated for pulmonary arterial hypertension to selexipag
RU2065744C1 (ru) Способ лечения гипертонической болезни ii стадии
CN1101572A (zh) 癌转移抑制剂及动物用癌转移抑制剂
SU1097334A1 (ru) Способ лечени ишемической болезни сердца
RU2135178C1 (ru) Способ повышения противоопухолевой эффективности в эксперименте
RU2252758C1 (ru) Способ спинальной анестезии с продлённой адреноганглиоплегией
Allon et al. Prolonged hypotension after initial minoxidil dose
Puybasset et al. Coronary effects of exogenous and endogenous bradykinin in conscious dogs
SU1210847A1 (ru) Способ лечени больных псориатическим артритом
CN1308008C (zh) 治疗冠心病的药物组合物
RU2219930C2 (ru) Способ лечения заболеваний печени
Voelkel Drug effects on the pulmonary circulation: an overview
CN120227382A (zh) 依普利酮在制备治疗类风湿性关节炎的药物中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication